Business
The Sphere In Las Vegas
LAS VEGAS, NEVADA- MARCH 12: Orbi, an emoji character, is displayed on the Sphere, a music and entertainment venue with the largest LED screen in the world on its exterior on March 12, 2025 in Las Vegas, Nevada. (Photo by Kevin Carter/Getty Images)

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

Following the huge spherical arena’s successful start in the entertainment capital of America, the country’s political capital is the next city pondering a Sphere. 

The operator of Las Vegas’ Sphere announced on Sunday that it will be developing its second US location at National Harbor in the Washington D.C. metropolitan area, aiming to build its first smaller-scale, 6,000-seat venue and adding to Sphere Entertainment’s “global network of Spheres” after the company signed a franchise agreement with the governing body of Abu Dhabi last July to build a sphere in the Middle East.

Sphere chart
Sherwood News

Rounding up

Though Sphere Entertainment only has one namesake landmark operating under its belt as of now, the company, previously under the umbrella of Madison Square Garden Entertainment before a spin-off, has a lot of seasoned executives in the live entertainment world.

Just like the iconic New York venue, the inside of the Sphere works as a sport and entertainment space that can accommodate up to 20,000 people. Hosting acts including the Backstreet Boys and U2 helped in to rake in some $156 million in the third quarter, up 37% year-on-year.

Tasked with growing its glowing ball business, the company has an additional revenue stream other than events — the arena’s LED-lined exterior, known as the Exosphere, used for advertising and signage — that, combined with sponsorship and suite license revenue, brought in an additional $11 million last quarter... along with a flurry of light pollution worries.

But even with that boost, the giant entertainment ball is far from profitable, with operating costs for the Sphere division of the company coming in nearly 50% higher than its revenue last quarter.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.